Kidney

Body system113 papersUBERON 0001008

  • Human trial5
  • Humans64
  • Animals5
  • Model organisms1
  • Cells2
  • In silico7

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 5Aug 2026: 6Sep 2026: 79Oct 2026: 23113
Scientific ReportsAnimals

TMEM174 deficiency shortens lifespan and stiffens vessels in mice

Knocking out the proximal tubule protein in mice shortened survival, whereas altering dietary phosphate intake regulated vascular calcification…Knocking out the proximal tubule protein in mice shortened survival, whereas altering dietary phosphate intake regulated vascular calcification, stiffness, and mortality.

medRxivHumansPreprint

NMR metabolomics improves prediction of cardiometabolic diseases

In 54,933 healthcare system participants, profiling 250 NMR biomarkers enhanced standard risk prediction for type 2 diabetes, kidney disease, and…In 54,933 healthcare system participants, profiling 250 NMR biomarkers enhanced standard risk prediction for type 2 diabetes, kidney disease, and liver disease.

MedicineHumans

Diverse diet protects kidneys while carb restriction raises risk

Genetically predicted unrestricted eating reduced renal failure risk (odds ratio 0.1269), while avoiding sugar and wheat increased susceptibility.Genetically predicted unrestricted eating reduced renal failure risk (odds ratio 0.1269), while avoiding sugar and wheat increased susceptibility.

Advanced ScienceIn silico

Facial foundation model estimates clinical biomarkers

Pretrained on 10 million images, the model assessed 62 biomarkers across eight physiological systems, reaching a median Pearson's r of 0.172 across…Pretrained on 10 million images, the model assessed 62 biomarkers across eight physiological systems, reaching a median Pearson's r of 0.172 across four cohorts.

Nature MedicineHuman trial

Semaglutide may protect kidneys by reducing vascular resistance

In a 52-week trial of 106 people with type 2 diabetes and chronic kidney disease, semaglutide reduced renal vascular resistance without altering…In a 52-week trial of 106 people with type 2 diabetes and chronic kidney disease, semaglutide reduced renal vascular resistance without altering coprimary imaging endpoints.

Journal of Geriatric OncologyHumans

Frailty and dementia link to poorer outcomes after cystectomy

In 3,600 older Medicare beneficiaries with bladder cancer, baseline frailty and dementia were associated with more care transitions and facility…In 3,600 older Medicare beneficiaries with bladder cancer, baseline frailty and dementia were associated with more care transitions and facility admissions after surgery.

NeurologyHumans

Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults

False-negative blood results occurred in 5.6% of participants compared with false positives in 2.8%, with mismatches tied to kidney function, BMI, and…False-negative blood results occurred in 5.6% of participants compared with false positives in 2.8%, with mismatches tied to kidney function, BMI, and clinical stage.